DIMENSIONAL FUND ADVISORS LP

Position in JNJ — Johnson & Johnson

CIK 354204 AUSTIN, TX

Back to JNJ Full portfolio

Position in JNJ

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$3,870,099,719

+$299,146,636 QoQ

Shares Held

15,832,514

-8.2% QoQ

Ownership

0.658%

of shares outstanding

% of Portfolio

0.82%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 86.87202803041892.ToString("F0")% Shared 7.1112143024159025.ToString("F0")% None 6.016757667165177.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $16,975,027,289 across 14 Drug Manufacturers - General names. JNJ ranks #1 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	15,832,514	$3,870,099,719
2	LLY	ELI LILLY & Co	3,895,925	$3,583,354,934
3	MRK	Merck & Co., Inc.	15,456,039	$1,859,206,929
4	ABBV	AbbVie Inc.	7,411,238	$1,611,870,150
5	NVS	Novartis AG	8,110,116	$1,238,820,217
6	AMGN	Amgen Inc	3,304,344	$1,162,633,435
7	BMY	Bristol Myers Squibb Co	18,762,589	$1,137,951,021
8	GILD	Gilead Sciences, Inc.	7,722,929	$1,076,344,612

All Filings in JNJ

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,870,099,719	15,832,514	-8.2%	Shares	Sole	2026-05-07
2025-12-31	$3,570,953,083	17,255,149	-4.3%	Shares	Sole	2026-02-12
2025-09-30	$3,344,220,655	18,035,922	-2.9%	Shares	Sole	2025-11-12
2025-06-30	$2,838,439,145	18,582,253	+9.9%	Shares	Sole	2025-08-12
2025-03-31	$2,803,210,930	16,903,105	+14.4%	Shares	Sole	2025-05-13
2024-12-31	$2,136,542,555	14,773,493	+4.5%	Shares	Sole	2025-02-13
2024-09-30	$2,291,052,428	14,137,063	+7.5%	Shares	Sole	2024-11-07
2024-06-30	$1,921,616,967	13,147,352	+16.2%	Shares	Sole	2024-08-09
2024-03-31	$1,790,409,445	11,318,095	+11.3%	Shares	Sole	2024-05-10
2023-12-31	$1,593,918,839	10,169,190	+10.6%	Shares	Sole	2024-02-07
2023-09-30	$1,431,919,551	9,193,705	+4.0%	Shares	Sole	2023-11-09
2023-06-30	$1,463,699,647	8,843,038	+5.1%	Shares	Sole	2023-08-09
2023-03-31	$1,303,951,915	8,412,593	+0.2%	Shares	Sole	2023-05-12
2022-12-31	$1,483,834,030	8,399,853	-3.6%	Shares	Sole	2023-02-09
2022-09-30	$1,423,887,578	8,716,256	-2.8%	Shares	Sole	2022-11-10
2022-06-30	$1,591,301,883	8,964,576	-5.1%	Shares	Sole	2022-08-12
2022-03-31	$1,674,401,692	9,447,620	-12.9%	Shares	Defined	2022-05-13
2021-12-31	$1,856,336,680	10,851,328	+4.6%	Shares	Defined	2022-02-09
2021-09-30	$1,675,435,399	10,374,213	+0.7%	Shares	Defined	2021-11-12
2021-06-30	$1,696,731,887	10,299,453	+5.2%	Shares	Defined	2021-08-12
2021-03-31	$1,609,279,371	9,791,782	-1.4%	Shares	Defined	2021-05-14
2020-12-31	$1,562,250,983	9,926,617	-2.5%	Shares	Defined	2021-03-08
2020-09-30	$1,515,060,198	10,176,385	-1.7%	Shares	Defined	2020-11-12
2020-06-30	$1,456,489,159	10,356,888	+1.8%	Shares	Defined	2020-08-13
2020-03-31	$1,333,651,108	10,170,450	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.